The Team


WingKai Chan


Chief Medical Officer and Director


Dr. Chan is the Chief Medical Officer and a Director of Axis Therapeutics. He is also the Head of Clinical, Asia Pacific of Athenex, Inc. He previously served as Director, National Center of Excellence for Clinical Trial and Research at the National University Hospital, Taiwan, and Medical Director in Roche Asia/Pacific and in that capacity, participated in the clinical development of a number of anti-cancer drugs such as: Rituxan, Herceptin and Xeloda, to name a few. Dr. Chan is a medical graduate of the University of New South Wales, Sydney, Australia and a Fellow of the Royal Australian College of Physicians. He is also a member of American Society of Clinical Oncology. Dr. Chan has authored many publications in clinical oncology over the course of his distinguished career.